Abstract:Cancer immune responses are complex cellular processes in which cytokine-receptor interactions play central roles in cancer development and response to therapy; dysregulated cytokine-receptor communication may lead to pathological processes, including cancer, autoimmune diseases, and cytokine storm; however, our knowledge regarding cytokine-mediated cell-cell communication (CCI) in different cancers remains limited. The present study presents a single-cell and pan-cancer-level transcriptomics integration of 41,900 cells across 25 cancer types. We developed a single-cell method to actively express 62 cytokine-receptor pairs to reveal stable cytokine-mediated cell communications involving 84 cytokines and receptors. The correlation between the sample-based CCI profile and the interactome analysis indicates multiple cytokine- receptor modules including TGFB1, IL16ST, IL15, and the PDGF family. Some isolated cytokine interactions, such as FN1-IL17RC, displayed diverse functions within over ten single-cell transcriptomics datasets. Further functional enrichment analysis revealed that the constructed cytokine-receptor interaction map is associated with the positive regulation of multiple immune response pathways. Using public TCGA pan-cancer mutational data, co-mutational analysis of the cytokines and receptors provided significant co-occurrence features, implying the existence of cooperative mechanisms. Analysis of 10,967 samples from 32 TCGA cancer types revealed that the 84 cytokine and receptor genes are significantly associated with clinical survival time. Interestingly, the tumor samples with mutations in any of the 84 cytokines and receptors have a substantially higher mutational burden, offering insights into antitumor immune regulation and response. Clinical cancer stage information revealed that tumor samples with mutations in any of the 84 cytokines and receptors stratify into earlier tumor stages, with unique cellular compositions and clinical outcomes. This study provides a comprehensive cytokine-receptor atlas of the cellular architecture in multiple cancers at the single-cell level.

Combinatorial proteomic analysis of intercellular signaling applied to the CD28 T-cell costimulatory receptor

CD28 Costimulation: From Mechanism to Therapy

T cell costimulation through CD28 depends on induction of the Bcl-xgamma isoform: analysis of Bcl-xgamma-deficient mice.

Exploring intercellular signaling by proteomic approaches

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ Isoform

Transcriptional reprogramming via signaling domains of CD2, CD28 and 4-1BB

Multiplex in Situ Tagging Technology for Highly Multiplexed Single-Cell Analysis

Motif-dependent Immune Co-Receptor Interactome Profiling by Photoaffinity Chemical Proteomics.

Conditional density-based analysis of T cell signaling in single-cell data

Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation

Integrated src kinase and costimulatory activity enhances signal transduction through single-chain chimeric receptors in T lymphocytes

[CD28 costimulation and checkpoint inhibition in T cells]

Profiling Proteins and Phosphorylation Sites During T Cell Activation Using an Integrated Thermal Shift Assay

Deciphering Cell–Cell Interactions with Integrative Single‐Cell Secretion Profiling

Quantitative Proteomics Analysis of Signalosome Dynamics in Primary T Cells Identifies the Surface Receptor CD6 As a Lat Adaptor–independent TCR Signaling Hub

Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity

Identification of Cytokine-Induced Cell Communications by Pan-Cancer Meta-Analysis.

CD28 Shapes T Cell Receptor Signaling by Regulating ZAP70 Activation and Lck Dynamics

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function

CD28 co-stimulation: novel insights and applications in cancer immunotherapy